Clinuvel Pharmaceuticals Limited (CUV.AX) - Stock Prices, Stock Peers & Analysis

Home
CUV.AX

Company Name	Clinuvel Pharmaceuticals Limited
Symbol	CUV.AX
Currency	AUD
Price	14.8
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	741,151,440
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0.33%
52-week-range	12.96 - 18.2
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Philippe Jacques Wolgen M.B.A., M.D., MBA
Website	https://www.clinuvel.com

An error occurred while fetching data.

About Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria